20/20 Biolabs Secures $500K Vermont Contract to Screen 4,500 Firefighters
AIDX•20/20 Biolabs’ OneTest multi-cancer early detection test will screen up to 4,500 Vermont firefighters over 12 months, generating approximately $500,000 in revenue. This follows Maryland’s program, which yielded $400,000 of $500,000 in reimbursements this quarter, versus $105,000 in state-funded revenue in the prior year.
1. Vermont Contract Award
20/20 Biolabs has been selected by the state of Vermont to provide its OneTest multi-cancer early detection blood test for a twelve-month firefighter screening initiative. The program targets up to 4,500 eligible firefighters and includes ultrasound services and medical oversight in partnership with National Diagnostic Services.
2. Expected Revenue and Financial Impact
The contract is anticipated to generate approximately $500,000 in testing revenues for 20/20 Biolabs through the end of 2026. Vermont retains the option to renew the agreement for two additional twelve-month periods, potentially extending the partnership through 2028.
3. Comparison with Maryland Program and State Funding Growth
This marks Vermont as the second state to fund OneTest for firefighters following Maryland, where the company processed over $500,000 of tests this quarter with roughly $400,000 reimbursed by the Maryland Department of Health. State-funded revenues have risen sharply from $105,000 in the prior year, reflecting increased public sector adoption.
4. Future Medicare Reimbursement Prospects
Recent legislation established a pathway for Medicare coverage of multi-cancer early detection tests starting in 2028, positioning 20/20 Biolabs to pursue reimbursement for OneTest. Data from firefighter screenings may support the company’s efforts to secure broader Medicare adoption and national rollout.
